crIpeC nAnomedicines’ micRodistribution in tUmour tiSsue

Project description

Delivering personalised nanomedicine at the tumour microenvironment

There are many diseases with unmet medical needs including cancer. Nanotechnology has emerged as a promising solution for encapsulating drugs and increasing their stability and biodistribution. The EU-funded ICARUS project is interested to improve the efficacy and therapeutic outcome of custom-made anti-cancer nanomedicines. These nanomedicines are biodegradable and demonstrate a great pharmacokinetic profile. During ICARUS, researchers plan to develop innovative state-of-the-art analytical methodologies that will help elucidate the distribution and behaviour of these nanomedicines at the tumour microenvironment. Results will pave the way for better-tolerated drugs in comparison to conventional treatment modalities.

Fields of science

• medical and health sciences › medical biotechnology › nanomedicine
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmacokinetics
• engineering and technology › nanotechnology › nano-materials

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.2.3.2.2. - Enhancing the innovation capacity of SMEs

Topic(s)

• INNOSUP-02-2019-2020 - European SME innovation Associate - pilot

Call for proposal

H2020-INNOSUP-2018-2020

See other projects for this call

Sub call

H2020-INNOSUP-2020-02

Funding Scheme

CSA-LSP - Coordination and support action Lump sum

Coordinator

CRISTAL DELIVERY BV

Net EU contribution

€ 128 875,00

Address

Oxfordlaan 55
6229 EV Maastricht
Netherlands

Region

Limburg (NL) › Zuid-Limburg

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Non-EU contribution

No data